We were a challenging case for sure, but he never gave up and curbed our treatment to us individually (with various medications and approaches that hadn't been tried before, etc.) because he wasn't afraid to think outside the box to do whatever was needed in order to help us fulfill our goal of having a family. ![]() We never felt rushed during our visits and he always took the time to answer all of our questions patiently and honestly. He has wonderful bedside manner and always provided us realistic expectations while still staying positive and optimistic along the way. From our very first appointment, both my husband and I knew it was a better fit and that we were in the best hands possible with him. My husband and I switched to him from another MD/office that we had been going to for a year and looking back now, switching to him was one of the best life-changing decisions we have ever made. He is passionate about the impact that patient advocacy and engagement and genomics can have in bringing about positive change for the patient, their families and caregivers.There are not enough stars to give Dr. He, his wife and children have had their genomes sequenced through different genome studies in the UK, including the Deciphering Developmental Disorders study, the 100,000 Genomes Project and the Next Generation Children study at Cambridge University but nothing has yet been found to explain their challenges. More importantly, however, Dr Steward is also a carer for his two young children both of whom have severe neurological disorders. He is also involved with similar initiatives for preterm birth and is actively working with different groups around the world to achieve both goals. He has recently been appointed to the International Cerebral Palsy Genomics Consortium Governance Council whose goal is to have cerebral palsy recognised as a disorder with a significant genetic basis. During his time at Wellcome Sanger Institute, Dr Steward was a senior member of the Human and Vertebrate Analysis and Annotation team where he led the initial gene analysis and annotation for human chromosome 10 (Deloukas et al., Nature 2004) and established an international collaboration investigating the genomic contribution of early-onset epileptic encephalopathies (Steward et al.,npj Genomic Medicine 2019).ĭr Steward is a member of the Genomics England Participant Panel, UK and the Simons Searchlight Community Advisory Committee in the USA. He is the patron for the Hope for Paediatric Epilepsy (HOPE) – London charity and is also a scientific advisor for the UK Infantile Spasms Trust. He spent 22 years at the Wellcome Sanger Institute, which is where he did his PhD, before moving to Congenica in 2016. He has around 28 years’ experience working with the human genome on the Wellcome Genome Campus, Cambridge UK. ![]() ![]() Dr Charles Steward is the Patient Advocacy and Engagement Lead at Congenica, a digital health company that assists clinicians and researchers to rapidly understand the genetic basis of rare diseases.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |